621 related articles for article (PubMed ID: 30571460)
1. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
3. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
[TBL] [Abstract][Full Text] [Related]
4. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.
Fidler TP; Xue C; Yalcinkaya M; Hardaway B; Abramowicz S; Xiao T; Liu W; Thomas DG; Hajebrahimi MA; Pircher J; Silvestre-Roig C; Kotini AG; Luchsinger LL; Wei Y; Westerterp M; Snoeck HW; Papapetrou EP; Schulz C; Massberg S; Soehnlein O; Ebert B; Levine RL; Reilly MP; Libby P; Wang N; Tall AR
Nature; 2021 Apr; 592(7853):296-301. PubMed ID: 33731931
[TBL] [Abstract][Full Text] [Related]
5. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
[TBL] [Abstract][Full Text] [Related]
7. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
[TBL] [Abstract][Full Text] [Related]
8. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux.
Dotan I; Yang J; Ikeda J; Roth Z; Pollock-Tahiri E; Desai H; Sivasubramaniyam T; Rehal S; Rapps J; Li YZ; Le H; Farber G; Alchami E; Xiao C; Karim S; Gronda M; Saikali MF; Tirosh A; Wagner KU; Genest J; Schimmer AD; Gupta V; Minden MD; Cummins CL; Lewis GF; Robbins C; Jongstra-Bilen J; Cybulsky M; Woo M
Commun Biol; 2022 Feb; 5(1):132. PubMed ID: 35169231
[TBL] [Abstract][Full Text] [Related]
10. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
11. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
[TBL] [Abstract][Full Text] [Related]
12. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
13. Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis.
Liu W; Östberg N; Yalcinkaya M; Dou H; Endo-Umeda K; Tang Y; Hou X; Xiao T; Fidler TP; Abramowicz S; Yang YG; Soehnlein O; Tall AR; Wang N
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35587375
[TBL] [Abstract][Full Text] [Related]
14. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
[TBL] [Abstract][Full Text] [Related]
15. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
[TBL] [Abstract][Full Text] [Related]
16. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
Dou H; Kotini A; Liu W; Fidler T; Endo-Umeda K; Sun X; Olszewska M; Xiao T; Abramowicz S; Yalcinkaya M; Hardaway B; Tsimikas S; Que X; Bick A; Emdin C; Natarajan P; Papapetrou EP; Witztum JL; Wang N; Tall AR
Circulation; 2021 Dec; 144(24):1940-1954. PubMed ID: 34846914
[TBL] [Abstract][Full Text] [Related]
17. PM
Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
19. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis.
Ait-Oufella H; Pouresmail V; Simon T; Blanc-Brude O; Kinugawa K; Merval R; Offenstadt G; Lesèche G; Cohen PL; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1429-31. PubMed ID: 18467644
[TBL] [Abstract][Full Text] [Related]
20. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
